Atherosclerosis progression in psoriatic arthritis patients despite the treatment with tumor necrosis factor-alpha blockers: A two-year prospective observational study-Reference-Cited by-同舟云学术

Atherosclerosis progression in psoriatic arthritis patients despite the treatment with tumor necrosis factor-alpha blockers: A two-year prospective observational study

Published:2014-10 Issue:5 Volume:81 Page:421-425
ISSN:1297-319X
Container-title:Joint Bone Spine
language:en
Short-container-title:Joint Bone Spine

Author:

Ramonda Roberta,Puato Massimo,Punzi Leonardo,Rattazzi Marcello,Zanon Marta,Balbi Giulia,Ortolan Augusta,Frallonardo Paola,Faggin Elisabetta,Plebani Mario,Zaninotto Martina,Lorenzin Mariagrazia,Pauletto Paolo,Doria Andrea

Publisher

Elsevier BV

Subject

Rheumatology

Reference40 articles.

1. The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people;Salaffi;Health Qual Life Outcomes,2009

2. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis;Han;J Rheumatol,2006

3. Inflammation and accelerated atherosclerosis: basic mechanisms;Doria;Rheum Dis Clin North Am,2005

4. Accelerated atherosclerosis in autoimmune rheumatic diseases;Shoenfeld;Circulation,2005

5. Subclinical atherosclerosis in patients with psoriatic arthritis: a case-control study. Preliminary data;Contessa;Reumatismo,2009

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of the Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Vascular Diseases: A Therapeutic Approach;Angiology;2024-01-03

2. Immune-mediated diseases and risk of incident cardiovascular diseases: a prospective cohort study;Rheumatology;2023-06-01

3. Holomycin, a novel NLRP3 inhibitor, attenuates cartilage degeneration and inflammation in osteoarthritis;Biochemical and Biophysical Research Communications;2023-05

4. Subclinical atherosclerosis in patients with hidradenitis suppurativa treated with TNF inhibitors;Skin Research and Technology;2023-03

5. Benefits of tumor necrosis factor inhibitors for cardiovascular disease in ankylosing spondylitis;International Immunopharmacology;2022-11